Rudolf Jaenisch is a Founding Member of Whitehead Institute and a pioneer of
transgenic science, in which researchers alter an animal's genetic makeup to
produce a variant of a human disease. Jaenisch has focused on creating
transgenic mice that enable his lab to study forms of cancer and neurological
diseases that have long baffled researchers.
Jaenisch's first breakthrough occurred in the 1970s when he demonstrated for
the first time that foreign DNA could be integrated into the DNA of early mouse
embryos; mice derived from these embryos carried the foreign genes in all of
their tissues. Subsequently, Jaenisch injected retrovirus into early mouse
embryos and showed that leukemia DNA sequences had integrated not only into the
mouse genome but also to its offspring. These mice were the first transgenic
animals in history.
Jaenisch also is a leader in the field of therapeutic cloning, also called
nuclear transfer, in which the genetic information from one cell is
transplanted into an unfertilized egg from which DNA has been removed. When
placed in a Petri dish, this egg develops into a blastocyst from which stem
cells can be taken. Jaenisch's therapeutic cloning research occurs exclusively
with mice, but he advocates using the same techniques with human cells in order
to advance embryonic stem cell research. Conversely, Jaenisch opposes human
reproductive cloning, in which the egg is placed not in a Petri dish but into
the uterus of a female, in the hope that it will develop into a fetus.
Today, the over-arching goal of Jaenisch's lab is to understand what
scientists call epigenetic regulation of gene expression. This refers to the
biological mechanisms that affect how genetic information is converted into
cell structures but that don't alter the genes in the process. Jaenisch's lab
is also investigating epigenetic mechanisms for certain types of cancer and for
brain development, where much of his work focuses on how conditions such as
Rett Syndrome occur.
Jaenisch received his doctorate in medicine from the University of Munich in
1967. Before coming to Whitehead, he was head of the Department of Tumor
Virology at the Heinrich Pette Institute at the University of Hamburg. He has
coauthored more than 300 research papers and has received numerous prizes and
recognitions including an appointment to the National Academy of Sciences in
2003.